YANGZHOU, China, Oct. 27, 2023 /PRNewswire/ -- Meihua
International Medical Technologies Co., Ltd. ("MHUA" or the
"Company") (NASDAQ: MHUA), a reputable manufacturer and provider of
Class I, II and III disposable medical devices with operating
subsidiaries in China, announced
today that its subsidiary Hainan Guoxie Technology Group Co., Ltd.
("Hainan Guoxie") has officially commenced construction of a
comprehensive medical industrial park project on the previously
acquired land around the Hainan Free Trade Port Boao Hope City
("Hope City"). The project aims to build a high-end comprehensive
medical industrial park. Earlier this year, The Company
successfully completed the final payment to acquire the land
located in the Hope City, securing a 50-year land use right for a
total area of 47,971 square meters.
The newly established comprehensive medical industrial park will
primarily focus on the research, development, production, and
testing of surgical robots. The company will collaborate with an
Israeli company for the development and production of surgical
robot technology, and the details of the partnership are still
being finalized. The surgical robots will mainly be used for remote
training of doctors and complex surgeries, among other
applications.
Upon completion, the comprehensive medical industrial park will
encompass the production and international trade of essential
conventional medical devices. Notably, it will house a
distinguished secondary hospital dedicated to offering a
comprehensive range of services, including comprehensive clinical
trials, stem cell extraction and storage, and advanced therapeutic
solutions, which services will be integrated with robotic
assistance. Anticipated to accommodate more than 300 individual
beds, this premier healthcare facility will be designed to cater
primarily to the discerning clientele and the elderly wellness
communities
Construction at the site is set to commence on October 27th, following meticulous preparations
encompassing land acquisition and blueprint designs. Having
obtained all required initial regulatory permits, the Company is
working toward a smooth start to the construction project.
As per the planning, the comprehensive industrial park will also
include a research and development center for innovative medical
products, an assembly production workshop for imported products,
and an export sales company. It will also provide integrated
solutions for hospital-based elderly care services.
During the groundbreaking ceremony, Mr. Yongjun Liu, Chairman of MHUA, commented: "We
are thrilled to witness the official commencement of the
comprehensive medical industrial park project in Hainan Free Trade
Port Boao Hope City. This marks the initiation of our first set of
projects in the overall development plan for this comprehensive
medical industrial park. The entire venture aims to provide
cutting-edge and innovative solutions for medical services in
Qionghai and the surrounding regions of Hainan. Leveraging the unique policy
advantages of Hope City and the exceptional wellness environment it
offers, we are committed to continuing to introduce exceptional
exported products and patents in research and technology. By
overcoming procurement challenges in the consumer market and
leveraging the distinctive advantages of Hainan and China mainland market, particularly after the
transformation of Hainan Province
into a free trade port by 2025, we are poised to seize the
opportunities of the era and deliver long-term, stable value growth
to MHUA's stakeholders and our esteemed clients."
About Meihua International Medical Technologies Co.,
Ltd.
Meihua International Medical Technologies is a reputable
manufacturer and provider of Class I, II and III disposable medical
devices with operating subsidiaries in China. The Company manufactures and sells
Class I disposable medical devices, such as HDPE bottles for
tablets and LDPE bottles for eye drops, throat strip, and anal
bags, and Class II and III disposable medical devices, such as
disposable identification bracelets, gynecological examination
kits, inspection kits, surgical kits, medical brushes, medical
dressing, medical catheters, uterine tissue suction tables, virus
sampling tubes, disposable infusion pumps, electronic pumps and
anesthesia puncture kits, among other products which are sold under
Meihua's own brands and are also sourced and distributed from other
manufacturers. The Company has received an international "CE"
certification and ISO 13485 system certification and has also
registered with the FDA (registration number: 3006554788) for over
20 Class I products. The Company has served hospitals, pharmacies,
medical institutions and medical equipment companies for over 30
years, providing over 1,000 types of products for domestic sales,
as well as over 120 products which are exported to more than 30
countries internationally across Europe, North
America, South America,
Asia, Africa and Oceania. For more information,
please visit www.meihuamed.com.
Forward-Looking Statements
This press release contains forward-looking statements as
defined by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. When the Company uses words such as
"may," "will," "intend," "should," "believe," "expect,"
"anticipate," "project," "estimate" or similar expressions that do
not relate solely to historical matters, it is making
forward-looking statements. Forward-looking statements are not
guarantees of future performance and involve risks and
uncertainties that may cause the actual results to differ
materially from the Company's expectations discussed in the
forward-looking statements. These statements are subject to
uncertainties and risks including, but not limited to, the
following: the Company's ability to achieve its goals and
strategies, and its ability to fully execute on the planned
agreement, the Company's future business development and plans of
future business development, including its ability to successfully
develop robotic assisted surgery systems and obtain licensure and
certification for such systems, financial conditions and results of
operations, product and service demand and acceptance, reputation
and brand, the impact of competition and pricing, changes in
technology, government regulations, fluctuations in general
economic and business conditions in China, and assumptions underlying or related
to any of the foregoing and other risks contained in reports filed
by the Company with the U.S. Securities and Exchange Commission
("SEC"). For these reasons, among others, investors are cautioned
not to place undue reliance upon any forward-looking statements in
this press release. Additional factors are discussed in the
Company's filings with the SEC, including under the section
entitled "Risk Factors" in its annual report on Form 20-F, as
amended, filed with the SEC on August 20,
2023, as well as its current reports on Form 6-K and other
filings, all of which are available for review at www.sec.gov. The
Company undertakes no obligation to publicly revise these
forward-looking statements to reflect events or circumstances that
arise after the date hereof.
For more information, please contact:
Janice Wang
Wealth Financial Services LLC
Phone:
+86 13811768599
+1 628 283 9214
Email: services@wealthfsllc.com
View original
content:https://www.prnewswire.com/news-releases/meihua-international-medical-technologies-co-ltds-subsidiary-officially-commences-construction-of-comprehensive-medical-industrial-park-in-hainan-free-trade-port-boao-hope-city-301969861.html
SOURCE Meihua International Medical Technologies Co., Ltd.
